burger
Features

Every tool you need for AI sales outreach

Prospecting with AI

Find leads with an appetite for your offer

Our best AI emails

Clients' favorite emails generated by AiSDR

Aircall integration

Add live phone conversations to sequences

AI Strategist

Generate 5 GTM plays from your website with AI

End-to-end AI Sales Outreach

All your bases covered within one solution

AI for HubSpot sales

Make the best of your CRM data

Is AiSDR a fit for me?

See if your business is AI-ready

AiSDR Website Illustrations | Starts and lightning icon 1
Speak with our AI

Let AiSDR try and convince you to book a meeting with us

Get a clear read on where the market stands today and how to get in front of it Grab my copy
menu arrow
Get a clear read on where the market stands today and how to get in front of it Grab my copy
menu arrow

AI Prospecting for AscellaHealth

AscellaHealth is a global healthcare and specialty pharmacy solutions provider dedicated to improving the quality of life for individuals with complex and chronic conditions.
laptop

Company data:

Company size:

200 employees

Industry

Healthcare

Headquarters:

Berwyn, Pennsylvania, USA

Investment round:

N/A

ARR:

N/A

Key stakeholders

These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates

Dea Belazi
Chief Executive Officer
Bill W. Oldham
Co-Founder, Chairman & President
Mario A. Patone
Chief Financial Officer

Latest news about AscellaHealth

Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates

AscellaHealth released its Q1 2025 Specialty & Rare Pipeline Digest™ on April 2, 2025, providing essential clinical drug updates on new, pending, and upcoming specialty and rare disease drug launches, biosimilars, and cell and gene therapies. The digest highlights key products impacting healthcare and drug spend, including biosimilars for Stelara and new therapeutic options for ATTR-CM, schizophrenia, and hemophilia[2][4][5].

AscellaHealth announced key executive promotions on April 15, 2025, with Donovan Quill as chief strategy officer and Bob Gilkin as chief commercial and growth officer for the Life Sciences business unit, supporting strategic growth and integrating strengths with affiliate Actum Pharma to aid biopharma companies in developing and marketing therapies[2][3].

AscellaHealth will sponsor and lead a key discussion at the World Orphan Drug Congress USA 2025, held from April 22-24, 2025. Donovan Quill will lead a roundtable on “The Truths and Myths of Building a Patient-First Exclusive Distribution Program,” focusing on optimizing supply chain processes and patient access to therapies for rare conditions[5].

Open job positions at AscellaHealth

This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

Business Unit Controller

AI sales outreach emails you can send to AscellaHealth

See samples of how AiSDR handles your outbound emails with the prospecting data available

See how AiSDR will sell to you.

Share your info and get the first-hand experience
Start scaling your sales outreach today!